Thailand Medicinal Cannabis Card Service Logo

ROYAL GAZETTE DOCUMENTS

Page 32

Vol. 142
GOVERNMENT GAZETTE
2 May B.E. 2568
Special Issue 183 Ngor

Notification of the National Drug System Development Committee on the National List of Essential Medicines (Herbal) (No. 2) B.E. 2568.

Whereas it is expedient to amend the Notification of the National Drug System Development Committee on the National List of Essential Medicines (Herbal) B.E. 2566 in order to drive and promote the use of herbal medicines in the health-service system in a concrete way, to promote wisdom so that it is developed further, and to strengthen the country’s medicine security, which is in accordance with the provisions of the Constitution, and in order that the herbal national essential medicines list is amended to keep pace with present circumstances.

By virtue of ข้อ 8 (4) of the Office of the Prime Minister Regulation on the National Drug System Development Committee B.E. 2551, the National Drug System Development Committee hereby issues the Notification as follows.

ข้อ 1 Repeals the text of item 2 of 2.1, carminative group relieving bloating and flatulence, of Group 2 gastrointestinal medicines, in Appendix 1 of the B.E. 2566 list, and replaces it with turmeric medicine, capsules and tablets, including hospital forms, basic list, indications: 1. relieve tightness, bloating, and flatulence; 2. relieve functional dyspepsia.

ข้อ 2 Adds as item 5 of 2.2, constipation-relieving group, of Group 2, triphala medicine, tablets, pills, capsules, infusion, powder, basic list, indication: a laxative; relieve constipation.

ข้อ 3 Adds as item 7 of Group 3 obstetric and gynaecological medicines, breast-milk tonic, infusion (รพ.), basic list, property: nourish breast milk; indication: increase breast-milk quantity in a woman after childbirth.

ข้อ 4 Repeals the text of item 9 of 4.1, antipyretic / internal-heat group, of Group 4 fever medicines, and replaces it with five-root medicine, powder, capsules, tablets, basic list, indication: relieve fever; drive out fever poison.


Vol. 142
GOVERNMENT GAZETTE
2 May B.E. 2568
Special Issue 183 Ngor

ข้อ 5 Repeals the text of Group 5 respiratory medicines in Appendix 1 and replaces the group. 5.1 cough / phlegm: nine named medicines, all basic list, indications to relieve cough, expel phlegm, and soothe the throat, including clove cough medicine, three emblic cough formulas, pickled-lime cough medicine, Isan folk cough medicine, triphala, prasamawaeng, and ammaritwathi. 5.2 cold-relieving: 1. prap chomphu thawip, capsules including hospital forms and pills (รพ.), basic list, indications: relieve a cold in the first stage and symptoms from weather allergy, and for allergic rhinitis with rhinorrhea, itchy nose, sneezing, and nasal congestion; 2. Andrographis paniculata (powder), capsules, tablets, pills, including hospital forms, basic list, indications: relieve sore throat, common-cold symptoms, and mild influenza symptoms; 3. Andrographis paniculata (extract), capsules, tablets, basic list, indications: relieve common-cold symptoms and mild influenza symptoms.

ข้อ 6 Repeals the text of item 2 of Group 7 musculoskeletal medicines and replaces it with ya kae lom kae sen, powder and capsules, including hospital forms, specific list, indication: treat wind in the channels; relieve muscle pain with numbness of the hands and feet.

ข้อ 7 Repeals the text of item 4 of Group 7 and replaces it with phlai formula 1, cream, basic list, indication: relieve swelling, bruising, sprain; the printed replacement also repeats a basic-list line with the indication relieve aches.

ข้อ 8 Repeals the text of item 19 of Group 7 and replaces it with chilli medicine (strength 0.025 w/w), gel, and hospital cream, gel, and ointment, basic list, indication: relieve joint and muscle pain (musculoskeletal pain).

ข้อ 9 Adds as items 25, 26, and 27 of Group 7: phlai formula 2, cream, basic list, indication: relieve body aches and sprain; chilli medicine (strength 0.075 w/w), lotion and cream, basic list, indication: relieve peripheral neuropathic pain; tha phra sen medicine, external liquid including hospital form, basic list, indication: treat wind chap pong; relieve pain from knee osteoarthritis; relieve aches, sprain, and strain.

ข้อ 10 Repeals the text of item 9 of Group 9 skin medicines and replaces it with aloe vera medicine (not less than 87 percent w/w), gel, basic list, indication: help reduce the severity of radiation dermatitis. ข้อ 10.1 adds as item 10 of Group 9 ya ya pakking, capsules (รพ.) and infusion (รพ.), specific list, indication: treat spoiled yellow fluid.

ข้อ 11 Repeals the text of item 1 of Group 11 anti-poison medicines and replaces it with rang chuet medicine, infusion (รพ.), basic list, indications: 1. take out intoxicating poison; 2. relieve insecticide or heavy-metal poison.


Vol. 142
GOVERNMENT GAZETTE
2 May B.E. 2568
Special Issue 183 Ngor

ข้อ 12 Adds as item 3 of Group 12 medicines to reduce cigarette craving, lozenge of white-flower-grass extract, hard lozenge, basic list, indication: reduce cigarette craving.

ข้อ 13 Repeals the text of item 1 of Group 14, medicines for brain and nervous-system symptoms, in Appendix 1 of the B.E. 2566 list, and replaces it with the following.

1. Cannabis extract oil containing cannabidiol (CBD) 100 milligrams per millilitre and delta-9-tetrahydrocannabinol (THC) in a ratio of CBD:THC greater than or equal to 20:1. Dosage form: drops in the oral cavity or on the oral mucosa (oromucosal drops). Specific list. Indications: 1. difficult-to-treat epilepsy; 2. drug-resistant epilepsy.

ข้อ 14 Repeals the text of items 6 and 7 of Group 15 other medicines in Appendix 1 and replaces them with Andrographis paniculata (powder) and Andrographis paniculata (extract), capsules and tablets, basic list, indication: use in a COVID-19 patient of low severity; item 7 as printed also carries a specific-list line with the indication treat wind sang.

ข้อ 15 Adds as item 9 of Group 15 ya suk sai-yat, capsules, powder, pills (รพ.), specific list, indication: help sleep and appetite. The clause as printed also says “and use the following text in place”.

ข้อ 16 Repeals Appendix 2 item (2) of 2.1 carminative group and replaces the turmeric monograph: capsules and tablets including hospital forms, basic list; powder of Curcuma longa L. rhizome with curcuminoids not less than 5.0 percent w/w and volatile oil not less than 6.0 percent v/w; indications functional dyspepsia and tightness, bloating, and flatulence; dose 500 milligrams to 1 gram four times a day after meals and at bedtime; contraindicated in bile-duct obstruction or hypersensitivity; interactions include warfarin, clopidogrel, apixaban, tacrolimus, and high-dose use with paclitaxel; caution in gallstones, pregnancy, and children; additional notes include comparison with omeprazole and a recommendation not to use more than 28 days for functional dyspepsia.

ข้อ 17 Repeals Appendix 2 item (9) of 4.1 and replaces the five-root monograph, powder, capsules, tablets, basic list, 20 grams each of five named roots in 100 grams of powder, indication relieve fever and drive out fever poison, with adult and child (6 to 12 years) doses, and a caution not to recommend use in a person suspected of dengue because it may mask symptoms.


Vol. 142
GOVERNMENT GAZETTE
2 May B.E. 2568
Special Issue 183 Ngor

ข้อ 18 to ข้อ 27 Repeal and replace Appendix 2 items of Group 5 respiratory medicines: clove cough pills (รพ.); emblic cough formula 3 pills; pickled-lime cough pills (รพ.); Isan folk cough liquid (รพ.); triphala tablets, pills, capsules, infusion including hospital forms; prasamawaeng tablets, powder (รพ.), pills (รพ.); add ammaritwathi powder and pills including hospital forms, with a note that khray khruea was removed because market material is in the genus Aristolochia, which WHO in 2002 declared a human carcinogen; prap chomphu thawip capsules and pills, whose formula includes 120 grams kanya-thet leaf; Andrographis paniculata powder and extract cold monographs with andrographolide quantities, doses, contraindications in allergy, pregnancy, and breastfeeding, and interactions through CYP 1A2, 2C9, and 3A4.

ข้อ 28 Repeals Appendix 2 item (2) of Group 7 and replaces ya kae lom kae sen, powder and capsules including hospital forms, specific list. Condition: order by a Thai traditional medicine practitioner, or an applied Thai traditional medicine practitioner, or a person assigned by the director of that medical facility, using Thai traditional medicine knowledge. Formula, in 150 grams: pepper seed 80 grams, cannabis leaf 40 grams, jet-mun-phloeng root 10 grams, ginger rhizome 8 grams, fennel 6 grams, black cumin 4 grams, white cumin 2 grams. Indication: treat wind in the channels; relieve muscle pain with numbness of the hands and feet. Dose: 1 to 4 grams twice a day before meals, morning and evening. Vehicle: 1 teaspoon (5 cc) of comb honey or kaffir-lime juice; if that cannot be found, half a glass (60 cc) of boiled water. Advice: increase the dose gradually; comb honey or kaffir-lime juice as vehicle helps reduce adverse effects. Contraindications: pregnant woman, breastfeeding woman, a person with fever. Cautions: peptic ulcer and reflux, because it is a hot-taste formula; for a diabetic patient use boiled water as vehicle. Adverse effects: may cause dizziness, confusion, dry throat, burning in the chest. Additional: the same explanation of wind in the channels as on the B.E. 2566 list.

ข้อ 29 Repeals Appendix 2 item (4) of Group 7, phlai formula 1 cream, basic list, 14 percent v/w volatile oil from Zingiber montanum rhizome, indication relieve swelling, bruising, sprain. ข้อ 30 repeals item (17) kho khlan mixed formula 2 decoction (รพ.). ข้อ 31 repeals item (19) chilli medicine 0.025 percent w/w. ข้อ 32 repeals item (9) of Group 9 aloe vera gel not less than 87 percent w/w. ข้อ 32.1 adds Appendix 2 item (10) ya ya pakking, capsules (รพ.) and infusion (รพ.), specific list. ข้อ 33 repeals Appendix 2 item (1) of Group 11 rang chuet infusion (รพ.).


Vol. 142
GOVERNMENT GAZETTE
2 May B.E. 2568
Special Issue 183 Ngor

ข้อ 34 Repeals the text of item (1) of Group 14, medicines for brain and nervous-system symptoms, in Appendix 2 of the B.E. 2566 list, and replaces it with the following.

(1) Cannabis extract oil containing cannabidiol (CBD) 100 milligrams per millilitre and delta-9-tetrahydrocannabinol (THC) in a ratio of CBD:THC greater than or equal to 20:1. Specific list. Dosage form: drops in the oral cavity or on the oral mucosa (oromucosal drops).

Condition of use: it shall be ordered by a paediatric neurologist or a doctor with experience in treating difficult-to-treat epilepsy.

Formula: cannabis extract with controlled quantities of cannabidiol (CBD) : delta-9-tetrahydrocannabinol (∆9-THC) in a ratio greater than or equal to 20:1, and THC must be controlled so as not to exceed 5 mg/mL.

Properties / indications: 1. difficult-to-treat epilepsy; 2. drug-resistant epilepsy.

Dose and method: start a medicine with CBD 1 to 3 mg/kg/day in the first month; increase slowly (CBD 1 to 5 mg/kg/day every 2 to 4 weeks until seizures are controlled) and without side effects. Maximum dose not more than 25 mg/kg/day, with THC ≤ 0.5 mg/kg/day.

Contraindications: 1. pregnancy (if pregnancy is suspected, perform a pregnancy test first); 2. a person with a history of cannabis allergy (or suspected allergy).

Warnings: use with care in a patient with a history of psychosis or schizophrenia; a patient with a history of uncontrolled mood disorder or uncontrolled aggression or behaviour problem; a patient with abnormal heart function (specifically severe cases, namely arrhythmia, coronary disease, cardiomyopathy, prolonged QTc); a person with a previous history of using a narcotic; a person with a history of using a product containing cannabis.

Interactions: take care in using this medicine together with valproate, clobazam, rufinamide, topiramate, zonisamide, and eslicarbazepine.

Cautions: this medicine may raise the patient’s liver enzymes. The person who orders it must follow liver function periodically, especially a person who also uses valproate.

Adverse effects: this medicine may cause drowsiness, especially when used with clobazam, loss of appetite, nausea and vomiting, and mood change.

Additional information: 1. difficult-to-treat epilepsy or drug-resistant epilepsy shall refer to the definition in the guideline of the Department of Medical Services; 2. there is not yet use data in a child patient under 1 year of age.


Vol. 142
GOVERNMENT GAZETTE
2 May B.E. 2568
Special Issue 183 Ngor

ข้อ 35 Repeals the text of item (5) of Group 15 other medicines in Appendix 2 of the B.E. 2566 list, and replaces it with ya prasakanya, capsules, powder (รพ.), capsules (รพ.), specific list. Formula, in 2,000 grams of powder: 125 grams each of dried ginger rhizome, long pepper, red sandalwood heartwood, white sandalwood heartwood, neem leaf, khonthi-khema leaf; 250 grams hulled pepper seed; 1,000 grams cannabis leaf. Indication: help sleep. Dose: 1 to 2 grams at bedtime; start low and increase. Vehicles: coconut water, comb honey, kaffir-lime juice, sugar, fresh krachai, bencha-thapthim water, chosen to suit the patient’s disease or symptoms, with the same examples as on the B.E. 2566 list; if no vehicle can be found, half a glass (60 cc) of boiled water. Contraindications: pregnant woman, breastfeeding woman; do not use with central-nervous-system depressants such as sleeping medicines or anticonvulsants; do not use with alcohol or anything containing alcohol. Cautions: anticoagulants and antiplatelets; may cause drowsiness, so avoid driving or machinery; take care with other Thai traditional formulas that contain cannabis. Additional: recommended in a person who cannot eat and cannot sleep; the same two classical-text citations as on the B.E. 2566 list.

ข้อ 36 and ข้อ 37 Repeal Appendix 2 items (6) and (7) of Group 15, Andrographis paniculata powder and extract for a COVID-19 patient of low severity, andrographolide 180 milligrams a day in three divided doses for 5 days, with allergy, pregnancy, and breastfeeding contraindications, CYP interactions, and a note that there is not yet clinical research in a COVID-19 patient under 12 years.


Vol. 142
GOVERNMENT GAZETTE
2 May B.E. 2568
Special Issue 183 Ngor

ข้อ 38 Repeals the text of item (9) of Group 15 in Appendix 2 and replaces it with ya suk sai-yat, capsules, powder, pills (รพ.), specific list. Condition: order by a Thai traditional medicine practitioner, or an applied Thai traditional medicine practitioner, or a person assigned by the director of that medical facility, using Thai traditional medicine knowledge. Formula, in 78 grams: cannabis leaf 12 grams, long pepper 11 grams, dried ginger rhizome 10 grams, pepper seed 9 grams, bunnak flower 8 grams, nutmeg 7 grams, kot kraduk 6 grams, black cumin 5 grams, samunwaeng bark 4 grams, hatsakhun-thet 3 grams, neem leaf 2 grams, camphor 1 gram. Indication: help sleep and appetite. Dose: for insomnia, 0.5 to 2 grams one to two times a day after breakfast and at bedtime; for loss of appetite, 0.5 to 2 grams one to two times a day before meals. Vehicle: 1 teaspoon (5 cc) of comb honey; if that cannot be found, half a glass (60 cc) of boiled water. Contraindications: pregnant woman, breastfeeding woman, a person with fever. Cautions: continuous use especially in liver or kidney abnormality because of camphor accumulation; peptic ulcer and reflux; central-nervous-system depressants and alcohol; for a diabetic patient use boiled water as vehicle. Adverse effects: may cause dry mouth, dry throat, flushed face. Additional: 1. dose relates to adverse effects; a higher dose is more likely to cause them, so a maximum of not more than 4 grams a day is recommended to help sleep; 2. taking with comb honey as vehicle helps reduce burning in the chest.

ข้อ 39 Adds as Appendix 2 item (5) of 2.2 constipation group, triphala tablets, pills, capsules, infusion, powder, basic list, 30 grams each of three terminalia and emblic fruit pulps in 90 grams of powder, indication a laxative and relieve constipation, dose 1 to 2 grams twice a day according to the strength of the elements (not more than 4 grams a day), with a caution to consult a Thai traditional medicine practitioner or medical personnel if use beyond 7 days is wanted, and additional notes on CYP1A2 and clopidogrel ecosprin because of the emblic.

ข้อ 40 Adds Appendix 2 item (7) of Group 3, breast-milk tonic infusion (รพ.), basic list, 20 grams each of five named ingredients in 100 grams of powder, indication increase breast-milk quantity in a woman after childbirth, 2.5 grams steeped in about 200 millilitres of hot water for 5 minutes three times a day after meals for 3 to 10 days or as the doctor orders. Additional: the formula comes from the pharmacopoeia of Wang Nam Yen Hospital, Sa Kaeo Province.


Vol. 142
GOVERNMENT GAZETTE
2 May B.E. 2568
Special Issue 183 Ngor

ข้อ 41 Adds Appendix 2 item (25) of Group 7, phlai formula 2 cream. ข้อ 42 adds item (26), chilli medicine 0.075 percent w/w lotion and cream for peripheral neuropathic pain. ข้อ 43 adds item (27), tha phra sen external liquid including hospital form, about 2 millilitres three times a day, external use only, not to be taken by mouth, shelf life not more than 1 year after production. ข้อ 44 adds Appendix 2 item (3) of Group 12, white-flower-grass extract lozenge, hard lozenge, basic list, indication reduce cigarette craving, with a warning that exceeding the recommended dose increases adverse-effect risk because of nitrate and potassium, and a note that there is not yet safety data in a pregnant or breastfeeding woman.

ข้อ 45 This Notification shall come into force from the day after the date of its publication in the Royal Gazette onwards.

Given on 12 March B.E. 2568. Prasert Chantararuangthong, Deputy Prime Minister, Chair of the National Drug System Development Committee.

This has not been officially translated. For the exact official text, please refer to the PDF. This is as accurate as possible from our team.

฿395Renewals ฿200Apply for your prescription